SalesTech Star

Tecsys Positioned as a Challenger in 2023 Gartner Magic Quadrant for Warehouse Management Systems

Tecsys has been recognized in this research twelve consecutive times.

Tecsys Inc., an industry leader in supply chain management software, is proud to announce its position as a Challenger in the 2023 Gartner Magic Quadrant for Warehouse Management Systems (WMS). This evaluation marks the twelfth consecutive time that Tecsys’ Elite™ WMS has been recognized by Gartner. Tecsys’ “Ability to Execute” and “Completeness of Vision” are the reasons why it was named a Challenger in the Gartner Magic Quadrant.

“WMS offerings continue to differ in areas such as usability, adaptability, decision support, scalability both up and down market, use of emerging technologies and life cycle cost,” Gartner states in the report. “Furthermore, customers increasingly favor suites that can support end-to-end supply chain and logistics process orchestration.” 1

“We feel it is an honor to be recognized once again as a Challenger in the Gartner Magic Quadrant,” says Peter Brereton, president and CEO of Tecsys. “We believe this achievement is a reflection of our dedication to our industry. We place great emphasis on building technology solutions that are designed to solve real-world supply chain challenges.”

Read More: Sift Appoints Identity And SaaS Go-To-Market Executive Chris Jones As Chief Revenue Officer

Elite™ WMS is part of Tecsys’ broader suite of solutions built on a digitally enabled, integrated platform designed to simplify complex supply chain operations. This no code/low code platform features extensible architecture and user-configurable rules to provide a high degree of system adaptability that accommodates unique operational requirements and enables vendor-agnostic automation. Inclusive of Distribution ERP, Warehouse Management, Transportation Management, Delivery Management, Pharmacy Inventory Management, Point of Use, and Analytics solutions, the Elite™ portfolio is designed to equip businesses with the technology and expertise needed to seamlessly execute operations, automate processes, and significantly enhance service levels to customers.

Tecsys takes great pride in its end-to-end value proposition to the healthcare market, in which Elite™ WMS and the Elite™ Healthcare platform serve as unifying technologies. The company has been evolving its product portfolio for this sector for over a decade, most recently announcing new hospital receiving functionality, thereby integrating supply chain operations from the receiving dock to the point of care. This portfolio is designed to accommodate a full range of healthcare supply chain workflows, including nursing and perioperative operations, pharmacy and med/surg distribution, outpatient inventory management and more. This, coupled with Tecsys’ adherence to the Drug Supply Chain Security Act (DSCSA) and 340B programs, widens the capabilities gap between Tecsys’ Elite™ Healthcare platform and other point solutions on the market. Further, Tecsys’ strategic industry partnerships make it easier than ever for health systems to tackle their end-to-end supply chain challenges. Through investment and innovation, Tecsys solutions are playing a pivotal role in the transformation and revitalization of the U.S. healthcare supply chain industry.

“We are excited about the future and the opportunity to continue providing innovative supply chain management solutions to our customers,” adds Brereton. “Our unwavering commitment is to stay at the forefront of this industry, and we will continue to invest in our platform to ensure that it remains a top choice for businesses seeking to optimize their supply chain operations.”

Read More: SalesTechStar Interview with Shaz Khan, CEO of Vroozi

Write in to psen@itechseries.com to learn more about our exclusive editorial packages and programs.

Brought to you by
For Sales, write to: contact@martechseries.com
Copyright © 2024- SalesTechStar. All Rights Reserved. Website Design:SalesTechStar | Privacy Policy
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.